Skip to main content
. Author manuscript; available in PMC: 2019 Feb 12.
Published in final edited form as: Mol Psychiatry. 2017 Oct 31;22(12):1680–1690. doi: 10.1038/mp.2017.210

Figure 3 – Comparison of EA EWAS effect sizes with the effect sizes in the never-smoker subsample and in smoking EWAS results.

Figure 3 –

Panel (a) displays the effect-size estimates in terms of R2 for the 9 lead probes, in descending order, and the lead probe’s corresponding effect size when re-estimated in the subsample of never smokers. Panel (b) displays the same information for the probes of the adjusted model with P < 1×10–5 (including the 9 lead probes), as well as the same probes’ effect-size estimates from two recent EWAS of smoking (n = 9,389, Joehanes et al., 2016), and maternal smoking (n = 6,685, Joubert et al., 2016). The smoking and maternal smoking estimates are only publicly available for probes associated at FDR < 0.05 in the respective EWAS.